UAB Ligence
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $3.3M
Investors
- 5
About UAB Ligence
UAB Ligence, founded in 2019 in Lithuania, focuses on echocardiography solutions. Arnas Karuzas is leading the firm as CEO as of 2024. Ligence offers echocardiography analysis and reporting software, particularly through its flagship product, Ligence Heart™. This web-based platform leverages deep learning technologies to support echocardiographic assessments. Key functionalities include automated image analysis for right and left ventricular evaluation, prediction of diastolic dysfunction, and a streamlined workflow that allows cardiologists to focus on patient interaction rather than multitasking during examinations. The software is designed for healthcare professionals within cardiology, particularly serving hospitals and clinics that require precise cardiac imaging and reporting. Ligence Heart is marketed primarily in Europe, North America, and select regions in Asia, targeting hospitals and specialized cardiovascular practices that utilize echocardiography in their diagnostic processes. The revenue structure of Ligence is built upon a subscription-based model for its Ligence Heart™ software, catering to healthcare institutions and professionals. Clients engage in annual or monthly subscription agreements, where they gain access to the platform’s suite of tools for echocardiography analysis. Additionally, Ligence may establish partnerships with hospitals and medical facilities for tailored integrations with existing PACS (Picture Archiving and Communication Systems) and EHR (Electronic Health Record) systems. Specific pricing plans for the subscription services are set to reflect the software's advanced capabilities and the scale of deployment across institutions, emphasizing its role in improving diagnostic workflows within the healthcare sector. Plans are in place to design and launch new features and enhancements for Ligence Heart™ in the coming year, with the intent to further penetrate the North American market by mid-2025.
Who invested in UAB Ligence
5 investors across 1 round
See all investors in UAB Ligence
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 12, 2024
Amount
$3.3M
Investors
Questions about UAB Ligence
Who invested in UAB Ligence?
UAB Ligence has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has UAB Ligence raised?
UAB Ligence has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did UAB Ligence last raise money?
UAB Ligence's most recent round on record is a Seed, in Oct 2024.
What does UAB Ligence do?
UAB Ligence, founded in 2019 in Lithuania, focuses on echocardiography solutions.
Where is UAB Ligence headquartered?
UAB Ligence is headquartered in Vilnius, Lithuania.
Which VCs invest in companies like UAB Ligence?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare it companies at UAB Ligence's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like UAB Ligence? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.